Manish Arora, BDS, MPH, PhD, FICD, is the Edith J. Baerwald Professor and Vice Chairman of the Department of Environmental Medicine and Public Health at the Icahn School of Medicine at Mount Sinai.
Dr. Arora is an environmental epidemiologist and exposure biologist. He graduated with a Ph.D. from the University of Sydney in 2006, and undertook postgraduate fellowship training at the Harvard School of Public Health. Dr. Arora’s research focuses on effects of prenatal and early childhood chemical exposures on life-long health trajectories. He is known for his work on biomarkers that utilize human deciduous and permanent teeth to reconstruct the timing of exposure to various harmful chemicals and essential nutrients, and biological response to those environmental factors. His methods are being applied to the study of outcomes that are national health priorities, including autism, schizophrenia, and Lou Gehrig’s disease (ALS). Dr. Arora has also undertaken research on the intersection of oral and systemic health with the environment. His work supports shared genetic risk factors between periodontal disease and various cancers (pancreatic, colorectal, and prostate cancers). He has also reported increased risk of periodontal disease and dental caries in those exposed to environmental metal toxicants. In recognition of his research, he was awarded the PECASE medal by the office of President Obama.
Multi-Disciplinary Training Area
Pharmacology and Therapeutics Discovery [PTD]-
2015
Fellowship of the International College of Dentists -
2014
$1.5 milllion New Innovator Award -
2005
IADR/Hatton Award -
Presidential Early Career Award for Scientists and Engineers (PECASE)
Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device and biotechnology companies to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their relationships with such companies.
Below are financial relationships with industry reported by Dr. Arora during 2020 and/or 2021. Please note that this information may differ from information posted on corporate sites due to timing or classification differences.
Company Founder:
- Linus Biotechnology
Equity (Stock or stock options valued at greater than 5% ownership of a publicly traded company or equity of any value in a privately held company)
- Linus Biotechnology
Other Activities: Examples include, but are not limited to, committee participation, data safety monitoring board (DSMB) membership.
- University invited speakerships
Service on Board of Directors: Service in a fiduciary capacity, such as an officer or director, for the following companies:
- Linus Biotechnology
Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.